Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort

Karolina Winsko-Szczęsnowicz; Małgorzata Pieniążek; Anna Polakiewicz-Gilowska; Marcin Kubeczko; Miloš Holánek; Miroslava Malejčíková; Renata Soumarová; Hana Študentová; Aleksandra Konieczna; Agnieszka Młodzińska; Justyna Żubrowska; Maja Lisik-Habib; Anika Pękala; Daniel Krejčí; Jan Šustr; Iveta Kolářová; Iwona Danielewicz; Magdalena Szymanik-Resko; Tomasz Ciszewski; Lenka Rušinová; Bogumiła Czartoryska-Arłukowicz; Aleksandra Łacko; Michał Jarząb; Zuzana Bielčiková; Renata Pacholczak-Madej; Mirosława Püsküllüoğlu

doi:10.1007/s12094-026-04236-5

February 2, 2026Clinical & Translational Oncology

Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort

View at Publisher

Ask AI

Bookmark

Share

Key Points

Metastatic triple-negative breast cancer patients treated with sacituzumab govitecan show varied outcomes, highlighting differences in clinical characteristics.
A significant proportion of 80% of patients exhibit a positive score status, emphasizing the effectiveness of the treatment.
Assessment included a detailed review of testing patterns and patient characteristics across a Central European cohort, using systematic analysis.
Findings underscore the necessity for standardized testing and better treatment approaches in this patient population.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Observational analysis reveals clinical characteristics and testing patterns in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan, suggesting care...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Winsko-Szczęsnowicz et al. (2026) studied this question.

synapsesocial.com/papers/69a76642badf0bb9e87dc53c https://doi.org/10.1007/s12094-026-04236-5

View at Publisher

Ask AI

Bookmark

Share

Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading